Contact this trialFirst, we need to learn more about you.
Norepinephrine-Dopamine Reuptake Inhibitor
SPN-812 ER for ADHD
Recruiting2 awardsPhase 3
Memphis, Tennessee
This trial is testing a new medication for kids with ADHD. It's open label, which means that everyone knows what medication is being tested. It's flexible dose, which means that the amount of medication given can be adjusted based on how the person responds. It's long-term, which means that the effects of the medication are studied over a long period of time. And it's multicenter, which means that it's being done at multiple locations.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.